selenium has been researched along with imiquimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devabattula, G; Gangadevi, V; Godugu, C; Pooladanda, V; Thatikonda, S | 1 |
| Guo, H; Li, M; Liu, H | 1 |
2 other study(ies) available for selenium and imiquimod
| Article | Year |
|---|---|
Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line; Glycogen Synthase Kinase 3 beta; Humans; Imiquimod; Inflammation; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Oxidation-Reduction; Phosphorylation; Psoriasis; Reactive Oxygen Species; Selenium; STAT3 Transcription Factor | 2021 |
Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways.
Topics: Animals; Cell Line; Dermatitis; Disease Models, Animal; Female; Humans; Hydrogen Peroxide; Imiquimod; Inflammation; Interleukin-17; Keratinocytes; Mice; Mice, Inbred BALB C; NF-kappa B; Peptides; Psoriasis; RAW 264.7 Cells; Selenium; Signal Transduction; Skin; Yeasts | 2022 |